# Utak Laboratories, Inc.

- Location (FDA's records): Mchenry, IL
- FDA decisions: 23 (1980–1991): 23 510(k) clearances
- Product codes: DIF (13), LAS (8), JJY (2)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K903061: Utak Laboratories Toxicology Control (Apr 12, 1991)
- K883147: Trace Elements Serum Toxicology Control (Oct 6, 1988)
- K862418: Benzodiazepines Toxicology Control (Nov 13, 1986)
- K862419: Serum Vancomycin Toxicology Control (Nov 13, 1986)
- K862421: Serum Clonazepam Toxicology Control (Nov 5, 1986)
- K862420: Utak-Stabbs Toxicology Control (Aug 4, 1986)
- K831736: Tricyclic Antidepressants (Jul 28, 1983)
- K831734: Amoxapine 8-Hydro-Xyamoxapine (Jul 26, 1983)

Source page: https://510kreport.com/company/utak-laboratories